Total Funding
34
67
Total FundingEquity Crowdfunding raised
Growth Score
-7 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
113369
PhorMed is a clinical stage biopharmaceutical company.
- Richard L. Chang: Co-Founder & CSO
- Ben Chang: Co-Founder, CEO and Chairman
About the Company
PhorMed offers repair therapy that helps the body repair itself. They provide RP-323, a compound that targets damaged or mutated cells due to cancer and viruses by passing through the blood-brain barrier and neurological cells, enabling medical research companies to treat unmet medical needs.
